Day: August 20, 2020

OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19

Written by Customer Service on August 20, 2020. Posted in Public Companies.

– Own developed SARS-CoV-2 Kit with PULB for COVID-19 uses real-time PCR (RT-PCR) technology on open PCR platforms, designed to provide results in approximately one hour– 100% Sensitivity and 97.3% Specificity demonstrated in isolated RNA – Inclusion of PCR-Compatible Universal Lysis Buffer (PULB) in the kit as a workflow option allows labs to circumvent the need for extraction equipment and reagentsGAITHERSBURG, Md., and HOLZGERLINGEN, Germany, Aug. 20, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that its subsidiary Curetis GmbH has obtained the CE mark certification in the European Union for its own SARS-CoV-2 Kit with PULB for the detection of SARS-CoV-2,...

Fynske Bank A/S: Delårsrapport 1. halvår 2020

Written by Customer Service on August 20, 2020. Posted in Earnings Releases And Operating Results.

Selskabsmeddelelse nr. 2020/12Flot andet kvartal for Fynske BankFynske Banks regnskab for første halvår af 2020 viser et acceptabelt resultat før skat på 10 mio. kr. efter et solidt andet kvartal. Trods uroen på de finansielle markeder som følge af COVID-19 endte det andet kvartal med et plus på 33 mio. kr.Efter en udfordrende start på 2020 leverede Fynske Bank et flot andet kvartal trods den globale uro på finansmarkederne verdenen over som følge af COVID-19.Det betyder, at bankens halvårsregnskab samlet set ender i et resultat før skat på 10 mio. kr.I samme periode sidste år lød overskuddet før skat på 47,8 mio. kr. Men set i lyset af pandemien betragter banken resultatet som acceptabelt, og direktør Petter Blondeau hæfter sig i særdeleshed ved den positive udvikling fra første kvartal, hvor et underskud før skat på 22,9 mio. kr. er...

Opera Limited announces second quarter 2020 financial results and formation of Nanobank

Written by Customer Service on August 20, 2020. Posted in Earnings Releases And Operating Results.

Opera’s total user base exceeded 360 million monthly active users in the second quarter and grew to a record 379 million users in JulyOpera News reported record monthly active users of 205 million in the second quarter, up 26% year-over-yearPC browser users grew to record 75 million monthly active users, up 15% year over year in the second quarterSecond quarter revenue of $55.4 million; trends improved as the quarter progressed and into the third quarterRecovery well underway with search and advertising revenues improving 32% in July from April and microlending loan disbursements growing 82% from June to JulySecond quarter adjusted EBITDA(1) of $2.9 million, and net income of $17.1 millionAnnouncing the formation of Nanobank – the combination of Opera’s microlending business and Mobimagic to create a category leader in emerging...

Meddelelse nr. 15/2020: Delårsrapport 1. januar – 30. juni 2020

Written by Customer Service on August 20, 2020. Posted in Earnings Releases And Operating Results.

Bestyrelsen for Strategic Investments A/S har på et møde d.d. behandlet selskabets delårsrapport for perioden 1. januar – 30. juni 2020.Resumé:Strategic Investments A/S’s resultat for 2. kvartal 2020 blev på DKK 26,6m før og efter skat svarende til et afkast på 12,0% og en stigning i indre værdi på DKK 0,08 pr. aktie.Resultatet for 1. halvår 2020 blev på DKK -71,4m før og efter skat svarende til et afkast på -22,1% og et fald i indre værdi på DKK 0,21 pr. aktie.Som oprindeligt planlagt afholdtes selskabets ordinære generalforsamling d. 16. april 2020 hvor generalforsamlingen vedtog udbetaling af udbytte på DKK 0,02 pr. aktie svarende til 3% af indre værdi.Selskabets egenkapital var d. 30. juni 2020 DKK 244,9m, svarende til en indre værdi af selskabets aktier på DKK 0,73 pr. aktie.I overensstemmelse med normal praksis offentliggjorde Strategic...

Vitalhub Corp. Announces Acquisition of Intouch With Health Inc.

Written by Customer Service on August 20, 2020. Posted in Mergers And Acquisitions.

TORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — VITALHUB CORP. (TSXV: VHI) (the “Company” or “VitalHub”), is pleased to announce today that it has acquired all the issued and outstanding shares (the “Acquisition”) of Intouch with Health Inc. (“Intouch”), a UK leader for patient flow management solutions.Through its “Intouch Patient Journey Platform,” Intouch specializes in delivering patient-focused flow management solutions that allow patients to more effectively move throughout a hospital. Intouch has evolved their solutions to support “virtual healthcare” patient interaction placing less reliance on face-to-face interactions. Intouch was founded in 1999 and is headquartered in Cirencester, Gloucestershire, United Kingdom with staff and operations, composed of 38 employees and contractors, located throughout the United Kingdom. Their...

Annovis Bio Actively Recruiting Patients for its Phase 2a Trials in Alzheimer’s and Parkinson’s Diseases

Written by Customer Service on August 20, 2020. Posted in Public Companies.

BERWYN, Pa., Aug. 20, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, is pleased to announce it has restarted patient recruitment for its Phase 2a clinical trial in AD which was suspended due to COVID-19 in March 2020, and initiated recruitment for its new Phase 2a clinical trial in AD and PD.The Company’s first Phase 2a trial of its lead compound, ANVS401, is a one-month study in 24 AD patients conducted in collaboration with the Alzheimer Disease Cooperative Study. The study is being conducted in six sites, including the University of California, San Diego, Johns Hopkins, Indiana University, Washington University, Cleveland Clinic, and Columbia University. Prior to suspension...

LAURENT-PERRIER: Communiqué de mise à disposition des documents préparatoires à l’Assemblée Générale

Written by Customer Service on August 20, 2020. Posted in Public Companies.

Laurent-PerrierSociété anonyme à Directoire et Conseil de Surveillanceau capital de 22.594.271,80 eurosSiège Social : 32, avenue de Champagne51150 Tours sur Marne335 680 096 RCS ReimsCOMMUNIQUETours-sur-Marne, le 20 août 2020Le Groupe Laurent-Perrier informe ses actionnaires que les documents préparatoires à son Assemblée Générale sont disponibles :– sur notre site internet : www.finance-groupelp.comOuLaurent-Perrier est l’un des rares groupes de maisons de champagne cotés en Bourse, qui soient dédiés exclusivement au champagne et focalisés sur le haut de gamme. Il dispose d’un large portefeuille de produits renommés pour leur qualité, autour des marquesLaurent-Perrier, Salon, Delamotte et Champagne de Castellane.Stéphane DalyacTéléphone 03.26.58.91.22www.finance-groupelp.comPièce jointex2 lpddr mise a dispo

Rheumatoid Arthritis Therapeutics Market to Reach USD 33,958.4 Million by 2025 | Global Market Size, Share, Analysis, Growth, Forecast [2018-2025]

Written by Customer Service on August 20, 2020. Posted in Mergers And Acquisitions.

Pune, Aug. 20, 2020 (GLOBE NEWSWIRE) — According to the report, the global rheumatoid arthritis therapeutics market is anticipated to exhibit 4.6% CAGR and reach valuation of US$ 33,958.4 Mn in 2025 from US$ 23,822.5 Mn in 2017.Exhibiting a high prevalence for rheumatoid arthritis, North America is forecast to lead the global rheumatoid arthritis therapeutics market in a recent report. In a report, titled “RHEUMATOID ARTHRITIS THERAPEUTICS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2018-2025”, Fortune Business Insights identifies numerous factors enabling growth in the market.The other highlights of the report include:• Targeted analysis of the impact of COVID-19 on the market;• Detailed study of the factors, trends, and constraints shaping the market;• Careful evaluation of the regional...

Correction: Alm. Brand A/S – Interim report Q2 2020

Written by Customer Service on August 20, 2020. Posted in Public Companies.

20 August 2020Announcement no. 35/2020Interim report Q2 2020Very satisfactory financial performance in Q2 2020 with a pre-tax profit of DKK 371 million, against DKK 145 million in Q2 2019. Positive contributions from the individual business areas as well as from the group’s portfolio of investment assets.Overall, Alm. Brand navigated the special situation caused by COVID-19 well and, on this basis, accelerated its development of digital customer interface solutions. The implementation of the changes announced in connection with the release of the 2019 financial statements is progressing as planned, and the ambitious financial targets for growth and profitability defined for the period until 2022 are maintained.CEO Rasmus Werner Nielsen:“We delivered strong quarterly results. All three business units – Non-life Insurance, Life Insurance...

Correction: Alm. Brand A/S – Delårsrapport for andet kvartal 2020

Written by Customer Service on August 20, 2020. Posted in Public Companies.

20. august 2020Selskabsmeddelelse nr. 35/2020Delårsrapport for andet kvartal 2020Meget tilfredsstillende resultatudvikling i andet kvartal 2020 med et overskud før skat på 371 mio.kr. mod 145 mio.kr. i andet kvartal 2019. Positive bidrag fra både de enkelte forretningsområder og koncernens beholdning af investeringsaktiver.Samlet har Alm. Brand navigeret godt gennem den særlige situation foranlediget af Covid-19 og har med afsæt heri accelereret udviklingen af digitale kundevendte løsninger. Implementeringen af de udmeldte forandringer i forbindelse med offentliggørelsen af årsregnskabet forløber fortsat planmæssigt og de ambitiøse finansielle målsætninger for vækst og lønsomhed frem mod 2022 fastholdes.Adm. direktør Rasmus Werner Nielsen udtaler:”Vi leverer et stærkt kvartalsresultat. Alle tre forretningsben – forsikring, pension og...

Day: August 20, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals